Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative Review
Author(s):
María Patricia Hernández-Mitre, Steven Y.C. Tong, Justin T. Denholm, Gregory J. Dore, Asha C. Bowen, Sharon R. Lewin, Balasubramanian Venkatesh, Thomas E. Hills, Zoe McQuilten, David L. Paterson, Susan C. Morpeth, Jason A. Roberts
Details:
Clinical Pharmacokinetics, Volume 61, Issue 10, 2022-10-01
Article Link: Click here
Affiliations:
- The University of Queensland
- Monash University
- UNSW Sydney
- Royal Melbourne Hospital
- Royal Brisbane and Women's Hospital
- The Alfred
- Monash Health
- The Kids Research Institute Australia
- The Kirby Institute
- Centre Hospitalier Universitaire de Nîmes
- Menzies School of Health Research
- The Peter Doherty Institute for Infection and Immunity
- UQ Centre for Clinical Research
- Perth Children's Hospital
- Middlemore Hospital, Auckland
- Medical Research Institute of New Zealand
- Central Auckland Health District

